NYSE · CIK 0000093314
VNRX VOLITIONRX LTD
Insider trading from SEC Form 4. Last filing 13 d ago. Close $0.21 on Oct 9, 2026, 0% from the 52-week low and -98% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
18
with a Form 4 at this company
Price and insider trades, last year
VNRXOct 9, 2026 · close 0.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at VOLITIONRX LTD, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Cameron John Reynolds President and CEO buy | $7,000 20,000 shares | +1% | 0% from low-65% from high | |
| 63Notable | Guy Archibald Innes director buy | $49k 96,153 shares | +10% | +10% from low-50% from high | |
| 70Notable | Cameron John Reynolds President and CEO buy | $56k 110,000 shares | +5% | +10% from low-50% from high | |
| 48Moderate | Timothy I Still director buy | $25k 48,076 shares | +3% | +10% from low-50% from high | |
| 29Weak | Cameron John Reynolds President and CEO buy | $9,885 15,000 shares | +1% | +57% from low-28% from high | |
| 46Moderate | Guy Archibald Innes director buy | $50k 78,125 shares | +9% | +52% from low-30% from high | |
| 53Moderate | Cameron John Reynolds President and CEO buy | $50k 78,125 shares | +3% | +52% from low-30% from high | |
| 41Moderate | Cameron John Reynolds President and CEO buy | $7,373 12,500 shares | +1% | +43% from low-32% from high | |
| 36Weak | Guy Archibald Innes director buy | $11k 20,000 shares | +2% | +29% from low-39% from high | |
| 44Moderate | Jacob Vincent Micallef Chief Scientific Officer buy | $22k 50,000 shares | +13% | 0% from low-52% from high | |
| 46Moderate | Cameron John Reynolds President and CEO buy | $8,730 20,000 shares | +1% | 0% from low-52% from high | |
| 31Weak | Guy Archibald Innes director buy | $100k 181,818 shares | +26% | - | |
| 46Moderate | Guy Archibald Innes director buy | $100k 174,764 shares | +40% | - | |
| 33Weak | Jacob Vincent Micallef Chief Scientific Officer buy | $25k 43,691 shares | +12% | - | |
| 52Moderate | Cameron John Reynolds President and CEO buy | $80k 139,811 shares | +7% | - | |
| 40Moderate | Timothy I Still director buy | $50k 87,382 shares | +6% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Gaetan Michel Chief Operating Officer | FTax withholding Common Stock | -608 | $0.25 | $154 | 12,232 | 13 d ago |
| Sep 28, 2026 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -284 | $0.25 | $72 | 16,284 | 13 d ago |
| Mar 17, 2026 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -5,251 | $0.19 | $998 | 331,338 | Mar 19, 2026 |
| Mar 17, 2026 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -7,003 | $0.19 | $1,331 | 407,267 | Mar 19, 2026 |
| Mar 17, 2026 | Jacob Vincent Micallef Chief Scientific Officer | FTax withholding Common Stock | -5,310 | $0.19 | $1,009 | 572,179 | Mar 19, 2026 |
| Mar 17, 2026 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -3,948 | $0.19 | $750 | 273,993 | Mar 19, 2026 |
| Mar 1, 2026 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -5,867 | $0.21 | $1,250 | 414,270 | Mar 3, 2026 |
| Mar 1, 2026 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -3,321 | $0.21 | $707 | 277,941 | Mar 3, 2026 |
| Mar 1, 2026 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -2,283 | $0.21 | $486 | 336,589 | Mar 3, 2026 |
| Feb 26, 2026 | Nicholas Plummer GC - Volition Diagnostics | AGrant or award Common Stock | +187,000 | $0.00 | $0 | 420,137 | Feb 27, 2026 |
| Feb 26, 2026 | Rodney Gerard Rootsaert Secretary | AGrant or award Common Stock | +119,000 | $0.00 | $0 | 281,262 | Feb 27, 2026 |
| Feb 26, 2026 | Kim Nguyen director | AGrant or award Common Stock | +178,000 | $0.00 | $0 | 305,816 | Feb 27, 2026 |
| Feb 26, 2026 | Ann-Louise Batchelor Group Chief Marketing Officer | AGrant or award Common Stock | +142,000 | $0.00 | $0 | 324,072 | Feb 27, 2026 |
| Feb 26, 2026 | Ethel Rubin director | AGrant or award Common Stock | +178,000 | $0.00 | $0 | 252,948 | Feb 27, 2026 |
| Feb 26, 2026 | Terig Hughes Chief Financial Officer | AGrant or award Common Stock | +202,000 | $0.00 | $0 | 684,970 | Feb 27, 2026 |
| Feb 26, 2026 | Cameron John Reynolds President and CEO | AGrant or award Common Stock | +486,000 | $0.00 | $0 | 3,115,547 | Feb 27, 2026 |
| Feb 26, 2026 | Guy Archibald Innes director | AGrant or award Common Stock | +178,000 | $0.00 | $0 | 1,252,967 | Feb 27, 2026 |
| Feb 26, 2026 | Gael Forterre Chief Commercial Officer | AGrant or award Common Stock | +149,000 | $0.00 | $0 | 338,872 | Feb 27, 2026 |
| Feb 26, 2026 | Jasmine Kway CEO - Singapore Volition | AGrant or award Common Stock | +173,000 | $0.00 | $0 | 418,614 | Feb 27, 2026 |
| Feb 26, 2026 | Jacob Vincent Micallef Chief Scientific Officer | AGrant or award Common Stock | +149,000 | $0.00 | $0 | 577,489 | Feb 27, 2026 |
| Feb 1, 2026 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -5,647 | $0.29 | $1,609 | 233,137 | Feb 3, 2026 |
| Feb 1, 2026 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -2,010 | $0.29 | $573 | 189,872 | Feb 3, 2026 |
| Feb 1, 2026 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -3,196 | $0.29 | $911 | 162,262 | Feb 3, 2026 |
| Jan 22, 2026 | Jacob Vincent Micallef Chief Scientific Officer | AGrant or award Common Stock | +35,400 | $0.00 | $0 | 428,489 | Jan 23, 2026 |
| Jan 22, 2026 | Kim Nguyen director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 127,816 | Jan 23, 2026 |
| Jan 22, 2026 | Nicholas Plummer GC - Volition Diagnostics | AGrant or award Common Stock | +44,700 | $0.00 | $0 | 238,784 | Jan 23, 2026 |
| Jan 22, 2026 | Jasmine Kway CEO - Singapore Volition | AGrant or award Common Stock | +42,000 | $0.00 | $0 | 245,614 | Jan 23, 2026 |
| Jan 22, 2026 | Rodney Gerard Rootsaert Secretary | AGrant or award Common Stock | +28,200 | $0.00 | $0 | 165,458 | Jan 23, 2026 |
| Jan 22, 2026 | Ethel Rubin director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 74,948 | Jan 23, 2026 |
| Jan 22, 2026 | Timothy I Still director | AGrant or award Common Stock | +90,000 | $0.00 | $0 | 1,625,458 | Jan 23, 2026 |
| Jan 22, 2026 | Phillip Barnes director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 67,368 | Jan 23, 2026 |
| Jan 22, 2026 | Ann-Louise Batchelor Group Chief Marketing Officer | AGrant or award Common Stock | +33,900 | $0.00 | $0 | 182,072 | Jan 23, 2026 |
| Jan 22, 2026 | Cameron John Reynolds President and CEO | AGrant or award Common Stock | +74,700 | $0.00 | $0 | 2,629,547 | Jan 23, 2026 |
| Jan 22, 2026 | Salvatore Thomas Butera CEO - Volition Veterinary | AGrant or award Common Stock | +53,400 | $0.00 | $0 | 375,203 | Jan 23, 2026 |
| Jan 22, 2026 | Alan Colman director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 257,364 | Jan 23, 2026 |
| Jan 22, 2026 | Gael Forterre Chief Commercial Officer | AGrant or award Common Stock | +38,100 | $0.00 | $0 | 191,882 | Jan 23, 2026 |
| Jan 22, 2026 | Mickie Henshall director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 44,206 | Jan 23, 2026 |
| Jan 22, 2026 | Terig Hughes Chief Financial Officer | AGrant or award Common Stock | +49,200 | $0.00 | $0 | 482,970 | Jan 23, 2026 |
| Jan 22, 2026 | Guy Archibald Innes director | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 1,074,967 | Jan 23, 2026 |
| Nov 17, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Common Stock | +20,000 | $0.35 | $7,000 | 2,554,847 | Nov 17, 2025 |
| Nov 1, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | FTax withholding Common Stock | -4,648 | $0.43 | $2,017 | 321,803 | Nov 4, 2025 |
| Nov 1, 2025 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -1,753 | $0.43 | $761 | 153,782 | Nov 4, 2025 |
| Nov 1, 2025 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -5,647 | $0.43 | $2,451 | 194,084 | Nov 4, 2025 |
| Nov 1, 2025 | Andrew Retter Chief Medical Officer | FTax withholding Common Stock | -4,588 | $0.43 | $1,991 | 146,568 | Nov 4, 2025 |
| Nov 1, 2025 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -3,197 | $0.43 | $1,388 | 137,258 | Nov 4, 2025 |
| Oct 14, 2025 | Guy Archibald Innes director | POpen-market purchase Common Stock | +96,153 | $0.51 | $49k | 1,062,967 | Oct 15, 2025 |
| Oct 14, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Common Stock | +110,000 | $0.51 | $56k | 2,534,847 | Oct 15, 2025 |
| Oct 14, 2025 | Timothy I Still director | POpen-market purchase Common Stock | +48,076 | $0.51 | $25k | 1,535,458 | Oct 15, 2025 |
| Oct 14, 2025 | Timothy I Still director | POpen-market purchase Warrant (Right to Buy)derivative | +48,076 | $0.01 | $481 | 48,076 | Oct 15, 2025 |
| Oct 14, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Warrant (Right to Buy)derivative | +110,000 | $0.01 | $1,100 | 110,000 | Oct 15, 2025 |
| Oct 14, 2025 | Guy Archibald Innes director | POpen-market purchase Warrant (Right to Buy)derivative | +96,153 | $0.01 | $962 | 96,153 | Oct 15, 2025 |
| Oct 4, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | FTax withholding Common Stock | -6,110 | $0.65 | $3,959 | 148,172 | Oct 7, 2025 |
| Oct 4, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | FTax withholding Common Stock | -5,834 | $0.65 | $3,780 | 326,451 | Oct 7, 2025 |
| Oct 4, 2025 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -5,389 | $0.65 | $3,492 | 155,535 | Oct 7, 2025 |
| Oct 4, 2025 | Jacob Vincent Micallef Chief Scientific Officer | FTax withholding Common Stock | -5,850 | $0.65 | $3,791 | 393,089 | Oct 7, 2025 |
| Oct 4, 2025 | Gaetan Michel Chief Operating Officer | FTax withholding Common Stock | -12,333 | $0.65 | $7,992 | 256,746 | Oct 7, 2025 |
| Oct 4, 2025 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -8,146 | $0.65 | $5,279 | 199,731 | Oct 7, 2025 |
| Oct 4, 2025 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -4,620 | $0.65 | $2,994 | 140,455 | Oct 7, 2025 |
| Sep 28, 2025 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -4,158 | $0.61 | $2,516 | 145,075 | Sep 30, 2025 |
| Sep 28, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | FTax withholding Common Stock | -5,604 | $0.61 | $3,390 | 154,282 | Sep 30, 2025 |
| Sep 28, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | FTax withholding Common Stock | -5,230 | $0.61 | $3,164 | 332,285 | Sep 30, 2025 |
| Sep 28, 2025 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -5,503 | $0.61 | $3,329 | 160,924 | Sep 30, 2025 |
| Sep 28, 2025 | Jacob Vincent Micallef Chief Scientific Officer | FTax withholding Common Stock | -5,568 | $0.61 | $3,369 | 398,939 | Sep 30, 2025 |
| Sep 28, 2025 | Gaetan Michel Chief Operating Officer | FTax withholding Common Stock | -11,362 | $0.61 | $6,874 | 369,079 | Sep 30, 2025 |
| Sep 12, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Common Stock | +15,000 | $0.66 | $9,885 | 2,624,847 | Sep 15, 2025 |
| Aug 15, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | AGrant or award Common Stock | +27,400 | $0.00 | $0 | 159,886 | Aug 19, 2025 |
| Aug 15, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | AGrant or award Common Stock | +33,991 | $0.00 | $0 | 337,515 | Aug 19, 2025 |
| Aug 15, 2025 | Gael Forterre Chief Commercial Officer | AGrant or award Common Stock | +9,727 | $0.00 | $0 | 166,427 | Aug 19, 2025 |
| Aug 15, 2025 | Terig Hughes Chief Financial Officer | AGrant or award Common Stock | +26,143 | $0.00 | $0 | 533,770 | Aug 19, 2025 |
| Aug 15, 2025 | Jasmine Kway CEO - Singapore Volition | AGrant or award Common Stock | +12,507 | $0.00 | $0 | 203,614 | Aug 19, 2025 |
| Aug 15, 2025 | Kim Nguyen director | AGrant or award Common Stock | +17,424 | $0.00 | $0 | 115,816 | Aug 19, 2025 |
| Aug 15, 2025 | Nicholas Plummer GC - Volition Diagnostics | AGrant or award Common Stock | +24,031 | $0.00 | $0 | 207,877 | Aug 19, 2025 |
| Aug 15, 2025 | Andrew Retter Chief Medical Officer | AGrant or award Common Stock | +19,524 | $0.00 | $0 | 151,156 | Aug 19, 2025 |
| Aug 15, 2025 | Rodney Gerard Rootsaert Secretary | AGrant or award Common Stock | +15,223 | $0.00 | $0 | 149,233 | Aug 19, 2025 |
| Aug 15, 2025 | Ethel Rubin director | AGrant or award Common Stock | +17,424 | $0.00 | $0 | 62,948 | Aug 19, 2025 |
| Aug 5, 2025 | Guy Archibald Innes director | POpen-market purchase Common Stock | +78,125 | $0.64 | $50k | 966,814 | Aug 6, 2025 |
| Aug 5, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Common Stock | +78,125 | $0.64 | $50k | 2,609,847 | Aug 6, 2025 |
| Aug 1, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | FTax withholding Common Stock | -8,620 | $0.64 | $5,517 | 132,486 | Aug 5, 2025 |
| Aug 1, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | FTax withholding Common Stock | -6,393 | $0.64 | $4,092 | 303,524 | Aug 5, 2025 |
| Aug 1, 2025 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -2,766 | $0.64 | $1,770 | 156,700 | Aug 5, 2025 |
| Aug 1, 2025 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -4,451 | $0.64 | $2,849 | 183,846 | Aug 5, 2025 |
| Aug 1, 2025 | Andrew Retter Chief Medical Officer | FTax withholding Common Stock | -6,142 | $0.64 | $3,931 | 131,632 | Aug 5, 2025 |
| Aug 1, 2025 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -4,279 | $0.64 | $2,739 | 134,010 | Aug 5, 2025 |
| Jul 24, 2025 | Terig Hughes Chief Financial Officer | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 507,627 | Jul 25, 2025 |
| Jul 24, 2025 | Cameron John Reynolds President and CEO | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 2,531,722 | Jul 25, 2025 |
| Jul 1, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | FTax withholding Common Stock | -6,177 | $0.77 | $4,743 | 141,106 | Jul 3, 2025 |
| Jul 1, 2025 | Salvatore Thomas Butera CEO - Volition Veterinary | FTax withholding Common Stock | -4,462 | $0.77 | $3,426 | 309,917 | Jul 3, 2025 |
| Jul 1, 2025 | Nicholas Plummer GC - Volition Diagnostics | FTax withholding Common Stock | -5,417 | $0.77 | $4,160 | 188,297 | Jul 3, 2025 |
| Jul 1, 2025 | Andrew Retter Chief Medical Officer | FTax withholding Common Stock | -4,401 | $0.77 | $3,380 | 137,774 | Jul 3, 2025 |
| Jul 1, 2025 | Rodney Gerard Rootsaert Secretary | FTax withholding Common Stock | -3,066 | $0.77 | $2,354 | 138,289 | Jul 3, 2025 |
| Jun 1, 2025 | Gael Forterre Chief Commercial Officer | FTax withholding Common Stock | -1,996 | $0.77 | $1,533 | 159,466 | Jul 3, 2025 |
| Jun 12, 2025 | Cameron John Reynolds President and CEO | POpen-market purchase Common Stock | +12,500 | $0.59 | $7,373 | 2,331,722 | Jun 16, 2025 |
| Jun 3, 2025 | Guy Archibald Innes director | POpen-market purchase Common Stock | +20,000 | $0.54 | $11k | 888,689 | Jun 4, 2025 |
| Jun 1, 2025 | Ann-Louise Batchelor Group Chief Marketing Officer | AGrant or award Common Stock | +18,341 | $0.00 | $0 | 147,283 | Jun 3, 2025 |
| Jun 1, 2025 | Salvatore Thomas Butera CEO, Volition Veterinary | AGrant or award Common Stock | +23,377 | $0.00 | $0 | 326,062 | Jun 3, 2025 |
| Jun 1, 2025 | Gael Forterre Chief Commercial Officer | AGrant or award Common Stock | +6,690 | $0.00 | $0 | 165,696 | Jun 3, 2025 |
| Jun 1, 2025 | Kim Nguyen director | AGrant or award Common Stock | +11,983 | $0.00 | $0 | 98,392 | Jun 3, 2025 |
| Jun 1, 2025 | Gaetan Michel Chief Operating Officer | FTax withholding Common Stock | -7,835 | $0.50 | $3,941 | 380,441 | Jun 3, 2025 |
| Jun 1, 2025 | Terig Hughes Chief Financial Officer | AGrant or award Common Stock | +17,406 | $0.00 | $0 | 407,627 | Jun 3, 2025 |
| Jun 1, 2025 | Jasmine Kway CEO - Singapore Volition | AGrant or award Common Stock | +8,327 | $0.00 | $0 | 191,107 | Jun 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Phillip Barnesdirector
- Ann-Louise BatchelorGroup Chief Marketing Officer
- Salvatore Thomas ButeraCEO - Volition Veterinary
- Alan Colmandirector
- Gael ForterreChief Commercial Officer
- Mickie Henshalldirector
- Terig HughesChief Financial Officer
- Guy Archibald Innesdirector
- Jasmine KwayCEO - Singapore Volition
- Jacob Vincent MicallefChief Scientific Officer
- Gaetan MichelChief Operating Officer
- Kim Nguyendirector
- Nicholas PlummerGC - Volition Diagnostics
- Andrew RetterChief Medical Officer
- Cameron John ReynoldsPresident and CEO
- Rodney Gerard RootsaertSecretary
- Ethel Rubindirector
- Timothy I Stilldirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.